top of page
NEWS & INSIGHTS
Dive into the Biopharma Space
Stay up-to-date on major biopharma news, deeper dives into specific companies and biopharma themes, and how it all relates to biopharma partners.
FEATURED POST
Ariel Victorio
ASGCT 2024: A Look at Participating Organizations
The American Society of Gene and Cell Therapy (ASGCT) is currently in full swing, bringing together the brightest minds in gene and cell...
Apr 19, 2024
San Diego Biotech Sector 2024
San Diego has a rich biotech ecosystem. From startups and small to mid-cap companies to major and well-established players. According to...
Apr 19, 2024
Major M&As Announced Recently - Late 2023 / Early 2024
The year 2024 continues to see significant mergers and acquisitions (M&A) activity in the biopharma sector. Here's a breakdown of 17...
Apr 12, 2024
Biopharma approvals, new data, M&A activity, and more - April 12th 2024
Immunotherapy company acquired for >$4B & 10 more updates...👇 Want a list of segmented biopharma companies or access to our online...
Apr 11, 2024
AACR'24 Clinical Data & Stock Moves
At this year's #cancer conference we saw not only pre-clinical, but also new clinical data presentations… Here's a glimpse at some...
Apr 8, 2024
Recent Biopharma Funding Activity - April 8th
Check out the following recent activity in the biopharma funding space. Take a closer look at 43 notable updates for this week: Want to...
Apr 5, 2024
Biopharma approvals, new data, M&A activity, and more - April 5th 2024
$13B acquisition deal + 10 more major updates...👇 Want a list of segmented biopharma companies or access to our online platform? Get...
Apr 4, 2024
Upcoming AACR ‘24 Clinical Readouts
American Association for Cancer Research Annual Meeting 2024 New clinical data at AACR (FIG. 1 📸): April 7, 2024 Replimune Group Inc....
Apr 2, 2024
Major acquisitions announced YTD in 2024
2024 has seen a slew of mergers and acquisitions. Here's a breakdown of 10 major deals within the pharmaceutical and biotechnology...
Apr 1, 2024
Recent Biopharma Funding Activity - April 1st
Check out the following recent activity in the biopharma funding space. This mix of private investments and public grants fuels important...
Mar 29, 2024
Biopharma approvals, new data, M&A activity, and more - March 29th 2024
Oral dual GLP-1/GIP obesity data + 14 more major updates...👇 🎯 → Approvals 🔬 → New data 🤝 → M&A activity Merck 🎯 FDA approved...
Mar 22, 2024
Biopharma approvals, new data, M&A activity, and more - March 22nd 2024
FDA approved gene tx for children w/ early-onset MLD + 13 updates...👇 Optinose 🎯 FDA approved XHANCE, the first and only medication...
Mar 18, 2024
Recent Biotech Funding Activity - March 18th
Check out the following recent activity in the biopharma funding space. This mix of private investments and public grants fuels...
Mar 15, 2024
Biopharma Approvals, New Data, M&A activity, and more...
First U.S. NASH/MASH approval + 12 updates...👇 Madrigal Pharmaceuticals 🎯 FDA Approved Rezdiffra™ (resmetirom) for the treatment of...
Mar 13, 2024
Cell & Gene Tx Companies in BioCapital Region
The BioCapital region is a hub for biotechnology innovation, with significant growth in the past few decades. Within the groundbreaking...
Mar 6, 2024
Biopharma Planned Trials & Regulatory Updates
Future clinical trials and regulatory activity..👇 Ventyx Biosciences 🔬 Initiate a Ph3 trial of VTX002 treating UC in H2 2024. Lytix...
Mar 4, 2024
Recent Biopharma Funding Updates
Public and private funding events 👇 – Private Company Funding Rounds – Tenomix 🏦 Closed $2M seed funding round. Kenai Therapeutics 🏦...
Feb 8, 2024
What’s Driving CD19 Cell Therapy to Autoimmune Disease?
Cell therapy offers a disease-modifying option for patients w/ refractory autoimmune disease. Autoimmune disease is a major unmet need...
Feb 6, 2024
Cell Therapy Spotlight: Pharm Country esp. Philadelphia: Is Pharm Country Becoming Cell Therapy Country?
When it comes to Pharm Country (NY, NJ, PA, CT, and RI), Pennsylvania is a hotbed for cell therapy (FIG. 1 📸). We found 39 companies in...
Feb 6, 2024
Big/Pharma Open for Business for Cell Therapy Collaborations
At the JP Morgan 2024 Healthcare Conference, large bio/pharma disclosed their 2024 M&A and collaboration strategies. A number of them are...
Feb 4, 2024
T-Cell Therapy Manufacturing Challenges Provide Opportunities for Vendors: Spotlight on IOVANCE (IOVA)
With an upcoming PDUFA date of February 24, 2024, we focus on Iovance (IOVA) in this post. 🧫 Tumor Infiltrating Lymphocytes (TILs) vs....
bottom of page